Search

everythinglearnresearchcommunity

for

Search:↓

New treatments for prostate cancer are less toxic and show promise, but more research is needed to enhance their effectiveness and reduce side effects.

Repurposing existing drugs can quickly and cheaply find new treatments for unmet medical needs.

Phosphodiesterase inhibitors like tadalafil can reduce cell growth in BPH caused by CD8+ T cells in low androgen conditions.

Upadacitinib may help treat difficult cases of systemic lupus erythematosus.

Some dibenzo compounds might help treat cancer with fewer side effects.

ALRN-6924 may prevent hair loss caused by chemotherapy.

GABAergic steroid precursors reduce ethanol withdrawal symptoms in certain mice.

New pregnane derivatives are effective at inhibiting an enzyme linked to hair loss and reducing oil gland activity.

Drug repurposing speeds up development, cuts costs, and uses known safe drugs, but faces challenges like regulations and patents.

New treatments for relapsing multiple sclerosis are more effective and convenient but have higher risks of serious side effects.

Baricitinib may not always prevent relapse in alopecia areata.

Plant-based compounds might be effective, low-side-effect treatments for prostate cancer by blocking a specific enzyme.

Certain drugs can worsen hair loss in people prone to androgenetic alopecia.

Combining dutasteride or finasteride with an α1 blocker is more effective for managing BPH than using either alone.

Using regulatory T cells and Rapamycin together improves chronic graft-versus-host disease treatment outcomes in mice.

Digital health technology improves health and medication adherence in kidney transplant patients.

AKR1D1 controls glucocorticoid levels and receptor activity in liver cells.

Monitoring new epilepsy drugs after they're sold is crucial to find rare and long-term side effects that initial tests might miss.

5-alpha reductase inhibitors can cause sexual side effects like erectile dysfunction and reduced sexual desire, sometimes lasting after stopping the drug.

MK-0773 is a moderate inhibitor of the SRD5A2 enzyme.

Prostate cancer cells can make their own androgens to activate the androgen receptor, and treatments like abiraterone may increase this ability, suggesting new therapies should target the entire steroid-making pathway.

More research is needed to confirm the long-term effects of oral drugs for chronic central serous chorioretinopathy.

Cardiovascular drugs can cause various skin problems, so recognizing these reactions is important.

Direct vasodilators and sympatholytic agents are still useful for certain conditions despite being less common due to side effects and newer drugs.

Dual-targeting therapies like Janus kinase inhibitors may treat both alopecia areata and other immune diseases.

Five existing drugs may help fight Swine Acute Diarrhea Syndrome Coronavirus.

A new hair loss treatment using dissolving microneedles was found to speed up hair growth and was more effective than daily use of common hair growth drugs.

Some herbs show promise as antiandrogenic agents.

Apremilast showed mixed results for treating severe alopecia areata.

The new assay can help develop products for hair re-growth.